Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingye Zhao

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Computational Intelligence and Neuroscience|August 12, 2022
Traffic Flow Prediction and Analysis in Smart Cities Based on the WND-LSTM ModelSuYuan Ma, MingYe Zhao
Frontiers in Pharmacology|April 6, 2023
Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysisXi Chen, Mingye Zhao, Lei Tian
Frontiers in Oncology|December 23, 2022
Cost-effectiveness analysis of sintilimab vs. placebo in combination with chemotherapy as first-line therapy for local advanced or metastatic oesophageal squamous cell carcinomaTaihang Shao, Mingye Zhao, Wenxi Tang
International Journal of Environmental Research and Public Health|February 15, 2022
Effectiveness and Cost-Effectiveness of Non-Pharmacological Interventions among Chinese Adults with Prediabetes: A Protocol for Network Meta-Analysis and CHIME-Modeled Cost-Effectiveness AnalysisYue Yin, Yusi Tu, Mingye Zhao, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2023
Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug PricingTaihang Shao, Mingye Zhao, Leyi Liang, et al.
Seminars in Cardiothoracic and Vascular Anesthesia|November 20, 2025
Trends and Regional Disparities of Cardiothoracic Anesthesia Procedures in China Between 2016 and 2023Mingye Zhao, Fenghao Yu, Yuwei Qiu, et al.
BMC Cancer|July 2, 2025
Racial, ethnic, sex, and age representation in clinical trials of radiopharmaceutical tumor therapy: a systematic review and meta-analysisMingye Zhao, Yunlin Jiang, Taihang Shao, et al.
Frontiers in Oncology|July 25, 2024
Comparison of systemic treatments for previously treated patients with unresectable colorectal liver metastases: a systematic review and network meta-analysisYunlin Jiang, Mingye Zhao, Wenxi Tang, et al.
BMC Cancer|February 9, 2024
Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysisYunlin Jiang, Mingye Zhao, Wenxi Tang, et al.
Frontiers in Immunology|November 17, 2022
A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancerTaihang Shao, Mingye Zhao, Leyi Liang, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Computational Intelligence and Neuroscience|August 12, 2022
Traffic Flow Prediction and Analysis in Smart Cities Based on the WND-LSTM ModelSuYuan Ma, MingYe Zhao
Frontiers in Pharmacology|April 6, 2023
Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysisXi Chen, Mingye Zhao, Lei Tian
Frontiers in Oncology|December 23, 2022
Cost-effectiveness analysis of sintilimab vs. placebo in combination with chemotherapy as first-line therapy for local advanced or metastatic oesophageal squamous cell carcinomaTaihang Shao, Mingye Zhao, Wenxi Tang
International Journal of Environmental Research and Public Health|February 15, 2022
Effectiveness and Cost-Effectiveness of Non-Pharmacological Interventions among Chinese Adults with Prediabetes: A Protocol for Network Meta-Analysis and CHIME-Modeled Cost-Effectiveness AnalysisYue Yin, Yusi Tu, Mingye Zhao, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2023
Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug PricingTaihang Shao, Mingye Zhao, Leyi Liang, et al.
Seminars in Cardiothoracic and Vascular Anesthesia|November 20, 2025
Trends and Regional Disparities of Cardiothoracic Anesthesia Procedures in China Between 2016 and 2023Mingye Zhao, Fenghao Yu, Yuwei Qiu, et al.
BMC Cancer|July 2, 2025
Racial, ethnic, sex, and age representation in clinical trials of radiopharmaceutical tumor therapy: a systematic review and meta-analysisMingye Zhao, Yunlin Jiang, Taihang Shao, et al.
Frontiers in Oncology|July 25, 2024
Comparison of systemic treatments for previously treated patients with unresectable colorectal liver metastases: a systematic review and network meta-analysisYunlin Jiang, Mingye Zhao, Wenxi Tang, et al.
BMC Cancer|February 9, 2024
Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysisYunlin Jiang, Mingye Zhao, Wenxi Tang, et al.
Frontiers in Immunology|November 17, 2022
A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancerTaihang Shao, Mingye Zhao, Leyi Liang, et al.
Pageof 4